Clicky

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock(FBIOP)

Description: Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.


Keywords: Medicine Cancer Biopharmaceutical Clinical Medicine Life Sciences Immunotherapy Autoimmune Disease Virotherapy Treatment Of Autoimmune Disease H. Michael Shepard

Home Page: www.fortressbiotech.com

FBIOP Technical Analysis

1111 Kane Concourse
Bay Harbor Islands, FL 33154
United States
Phone: 781 652 4500


Officers

Name Title
Dr. Lindsay Allan Rosenwald Exec. Chairman, Pres & CEO
Mr. Michael S. Weiss Esq. Vice Chairman & Exec. Vice Chairman of Strategic Devel.
Dr. George C. Avgerinos Sr. VP of Biologics Operations
Ms. Robyn M. Hunter Exec. Officer
Mr. David Jin CFO & Head of Corp. Devel.
Mr. Samuel Berry Gen. Counsel & Corp. Sec.
Dr. Thomas F. Schaible Project Leader of Inflammatory Bowel Disease

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 1.3576
IPO Date: 2017-11-14
Fiscal Year End: December
Full Time Employees: 173
Back to stocks